Federal healthcare policy related to personalized and precision medicine, preventive healthcare, telehealth, physician autonomy, FDA and DEA regulatory policy, Medicare reimbursement, and patient access to innovative therapies.
2026 · 2nd Quarter (Apr 1 - June 30)
PERSONALIZED HEALTH ASSOCIATION
Filed by DUDDINGTON GLOBAL STRATEGIES LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- DUDDINGTON GLOBAL STRATEGIES LLC
- Filing UUID
- 21648aea-b521-45cf-ba7e-d24ed724b75b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Federal healthcare policy related to personalized and precision medicine, preventive healthcare, telehealth, physician autonomy, FDA and DEA regulatory policy, Medicare reimbursement, and patient access to innovative therapies.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.